Replies to post #530733 on NorthWest Biotherapeutics Inc (NWBO)

[Dr Bala]

Bluebook examples don't mean a thing in a particular trial.

[hoffmann6383]

The other was DCTH where nobody saw an issue until the FDA looked at the NDA data and saw that certain batches were killing people, and nobody knew why.

These comparisons are utter bullshit.

There were no serious side effects with Murcidencel.

Have a great one pal! by.

[dstock07734]

"Direct experience"? You are in IT business. Right? How direct your experience can be!

[W_W]

You are pointing out a possibility, which is valid, just like it is possible you may win the last Powerball. But what is the likelihood?

Further, if Merck didn't find anything different from the published data, Will they buy? Please dispute on that.

I think the odd is on my side. You are on a losing battle!

[dennisdave]

I agree with what you are saying however a peer-reviewed journal means two things. Scientific validation and an incredible PR boost for the drug both are very important to BP.

I personally believe there will be a BO after MHRA has approved DCVAXL Murcidencel. After Murcidencel has been approved means that the production capacity has been approved for without a BP has nothing. Therefore Im, as I have said here a few times before, Toucan will sell Advent to that same BP as well. BP will buy NWBO and Advent in a package deal.